University of Central Florida's Cytosen has been acquired in an all-stock deal by Kiadis Pharma, in a transaction potentially worth up to $70m.
Merck & Co will pay up to $773m to acquire biopharmaceutical developer Tilos Therapeutics, based on research at Harvard Medical School and Brigham & Women’s Hospital.
Stanford spinout Tableau Software has agreed to a $15.7bn all-stock acquisition by Salesforce, six years after completing a $254m initial public offering on the New York Stock Exchange.
Eriez is now the largest shareholder in Cardiff University-founded power fault protection technology spinout FaultCurrent, having previously invested a seven-figure sum.
Bio-Techne has bought University of Minnesota-founded genome editing platform operator B-Mogen Biotechnologies to solidify a business relationship that dates to 2016.
USI-founded fake news detection technology developer Fabula AI has been scooped up by Twitter, which will employ the spinout's talent to remove spam and abuse from its platform.
Fund manager Neil Woodford has sold his entire stake in Oxford Sciences Innovation, worth close to $70m, as his funds have come under increasing pressure.
A member of NYU's Future Labs incubator network, virtual receptionist developer Bowtie.ai has been acquired by wellness services software developer Mindbody.